Clinical Trial Update: A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pharmacokinetics, pharmacodynamics, safety, and tolerability of andexanet after betrixaban dosing; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding

Drugs mentioned

• andexanet (andexanet alfa)
• betrixaban (betrixaban)

Snippet

Sponsor: Portola Pharmaceuticals | Conditions: Bleeding | Phase 2 | Status: TERMINATED | Results posted: 2020-08-19